AU757920B2 - Genes of the dead box protein family, their expression products and use - Google Patents

Genes of the dead box protein family, their expression products and use Download PDF

Info

Publication number
AU757920B2
AU757920B2 AU50365/99A AU5036599A AU757920B2 AU 757920 B2 AU757920 B2 AU 757920B2 AU 50365/99 A AU50365/99 A AU 50365/99A AU 5036599 A AU5036599 A AU 5036599A AU 757920 B2 AU757920 B2 AU 757920B2
Authority
AU
Australia
Prior art keywords
nucleic acid
polypeptide
seq
allergies
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50365/99A
Other languages
English (en)
Other versions
AU5036599A (en
Inventor
Karin Bohnet
Christoph Huls
Stefan Mullner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Research and Technologies GmbH and Co KG
Original Assignee
Aventis Research and Technologies GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Research and Technologies GmbH and Co KG filed Critical Aventis Research and Technologies GmbH and Co KG
Publication of AU5036599A publication Critical patent/AU5036599A/en
Application granted granted Critical
Publication of AU757920B2 publication Critical patent/AU757920B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
AU50365/99A 1998-07-22 1999-07-10 Genes of the dead box protein family, their expression products and use Ceased AU757920B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19832783 1998-07-22
DE19832783 1998-07-22
PCT/EP1999/004892 WO2000005388A1 (fr) 1998-07-22 1999-07-10 Genes de la famille des proteines de la boite dead, leurs produits d'expression et leur utilisation

Publications (2)

Publication Number Publication Date
AU5036599A AU5036599A (en) 2000-02-14
AU757920B2 true AU757920B2 (en) 2003-03-13

Family

ID=7874812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50365/99A Ceased AU757920B2 (en) 1998-07-22 1999-07-10 Genes of the dead box protein family, their expression products and use

Country Status (5)

Country Link
EP (1) EP1098985A1 (fr)
JP (1) JP2002524029A (fr)
AU (1) AU757920B2 (fr)
CA (1) CA2335646A1 (fr)
WO (1) WO2000005388A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315540A (zh) * 2000-03-24 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人解螺旋酶13和编码这种多肽的多核苷酸
CN1315543A (zh) * 2000-03-27 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人rna解旋酶10和编码这种多肽的多核苷酸
CN1324946A (zh) * 2000-05-19 2001-12-05 上海博德基因开发有限公司 一种新的多肽——人atp依赖的rna解螺旋酶11和编码这种多肽的多核苷酸

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19545126A1 (de) * 1995-12-04 1997-06-05 Hoechst Ag ATP- und Nukleinsäure-bindendes Protein mit Helikase-Eigenschaften

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBL SEQUENCE DATABASE ACC # U59321 *
EMBL SEQUENCE DATABASE ACC # X52648 *
EMBL SEQUENCE DATABASE ACC # X65053 *

Also Published As

Publication number Publication date
CA2335646A1 (fr) 2000-02-03
AU5036599A (en) 2000-02-14
EP1098985A1 (fr) 2001-05-16
JP2002524029A (ja) 2002-08-06
WO2000005388A1 (fr) 2000-02-03

Similar Documents

Publication Publication Date Title
Walker et al. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding
TWI327067B (en) Antifungal protein and usage thereof
WO1998013486A1 (fr) Nouveaux genes associes a une resistance accrue aux maladies chez les plantes
US6218142B1 (en) Nucleic acid molecules encoding polypeptides having the enzymatic activity of an RNA-directed RNA polymerase (RDRP)
EP0690874B1 (fr) Substances et procedes relatifs a des proteines qui ont une interaction avec la kinase caseine i
AU757920B2 (en) Genes of the dead box protein family, their expression products and use
AU752382B2 (en) Map kinase phosphatase mutant
KR20000068498A (ko) 키나제 단백질 및 이의 용도
JPH09509319A (ja) Ｒｎａ修正酵素およびその使用方法
Rutherford et al. Cloning, structural analysis, and expression of the glycogen phosphorylase-2 gene in Dictyostelium.
JP2002514423A (ja) 組換え植物ｅ２ｆペプチドを発現するトランスジェニック植物細胞
Rumsfeld et al. High-throughput assay for inorganic pyrophosphatases using the cytosolic enzymes of Saccharomyces cerevisiae and human as an example
US7732209B2 (en) Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
Watanabe et al. Cloning and sequencing of the gene for a Tetrahymena fimbrin-like protein
US6297360B1 (en) Amphipathic protein-1
Akkaya et al. Purification and N-Terminal Sequence-Analysis of Pea Chloroplast Protein Synthesis Factor EF-G
CN108314728B (zh) 一种紫花苜蓿胰蛋白酶抑制剂MT-mth2-89i19及其编码基因与应用
JP3106188B1 (ja) 植物ウイルスの感染に関与する宿主遺伝子及びポリペプチド
AU758898B2 (en) Human deadenylating nuclease, its production and its use
EP0851912A1 (fr) Nouveaux facteurs modifiant la transcription des genes et leurs procedes d'utilisation
US7273724B1 (en) Polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same
US6765128B1 (en) Method of using a pathogen-activatable map kinase to enhance disease resistance in plants
CZ20004136A3 (cs) Humánní deadenylační nukleasa, způsob její přípravy a její použití
KR19990015342A (ko) 사람의 전사조절 매개체 유전자, 이 유전자의 생성물 및 이 유전자에 의해 형질전환된 균주
WO2001002432A1 (fr) Proteine contenant sh3, adn et utilisations associees

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)